Learning Center

Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Includes Multiple Live Events. The next is on 12/09/2023 at 10:00 AM (EST)

    Course Date: December 9 & 10, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    December 9 & 10, 2023.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices.
    2. Perform a precision assessment and appreciate the requirement for clinical care.  
    3. Identify the anatomy relevant to clinical DXA scanning. 
    4. Implement consistent and appropriate technical acquisition and analysis techniques.  
    5. Perform a fracture risk assessment using FRAX. 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
    7. Understand how specific medical conditions and medications affect bone density. 
    8. Demonstrate how to access features within the DXA software. 
    9. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
    10. Recognize how technical errors impact clinical interpretation and patient care.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Registration Fee

    image



    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 13.0 Category A continuing education credits.

    Date of most recent Review or Update: This activity was most recently reviewed and renewed March 24, 2023.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - Day 1 - All times Eastern (NYC/USA)

    image

    Schedule - Day 2 - All times Eastern (NYC/USA)

    image

    Maureen A. Costello, AAS, RT(R), CBDT

    Radiologic Technologist

    University of Chicago Hospitals

    Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.

    Disclosure: No Financial Relationships to Disclose

    Anita Colquhoun, RTNM, MRT(N), CDT

    Charge Technologist

    Women's College Hospital

    Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

    Disclosure: No Financial Relationships to Disclose.

    Diane Krueger, BS, CBDT

    Program Manager Osteoporosis Clinical Research Program

    UW Osteoporosis Clinic

    Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.

    Disclosures: Consulting Fee: Amgen; Contracted Research: Radius 

    Course Planning Committee

    JoAnn Caudill, RT(R)(M)(BD), CBDT  No Financial Relationships to Disclose 
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose 
    Larry G. Jankowski, CBDT No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
    Michelle Kochanski ,BSIT, RT(R), CBDT No Financial Relationships to Disclose 
    Diane Krueger, BS, CBDT Consulting Fee: Amgen; Contracted Research: Radius

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    December 2023 Course Faculty

    Maureen A. Costello, AAS, RT(R), CBDT No Financial Relationships to Disclose
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose
    Diane Krueger, BS, CBDT Disclosures: Consulting Fee: Amgen; Contracted Research: Radius 

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 12/09/2023 at 10:00 AM (EST)

    Course Date: December 9 & 10, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    December 9 & 10, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Dr Neil Binkley MD, CCD,

    Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

    Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research 

    Christopher Shuhart MD, MHA, CCD

    Director of the Bone Health and Osteoporosis Center

    Swedish Medical Group

    Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) from 2019-2020, with multiple years in Executive and Board of Directors roles, and has served on numerous ISCD committees and task forces. He received ISCD's Paul Miller Service Award in 2022.

    He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was the Organizing Chair for the 2019 ISCD Position Development Conference (PDC) in Kuala Lumpur, Malaysia, as well as lead author of the 2019 PDC Executive Summary. He is the Administrative Chair for the 2023 PDC.

    Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.

    Disclosure: No financial relationships to disclose

    S. Bobo Tanner, MD, CCD

    Director of the Vanderbilt Osteoporosis Clinic

    Vanderbilt University Medical Center

    Bobo Tanner, MD, CCD is an Assistant Professor of Medicine at Vanderbilt University Medical Center in Nashville, TN in the Divisions of Rheumatology, Allergy and Immunology. He is the Director of the Vanderbilt Osteoporosis Clinic. His education includes an AB from Harvard University, and an MD from Wake Forest University. He completed his training in Internal Medicine, Rheumatology, and Allergy & Immunology at Vanderbilt University and served as Registrar in Rheumatology at the Royal Free Hospital, London, England. Dr. Tanner has been a member of the International Society for Clinical Densitometry (ISCD) since 1996 and is a Past- President of the ISCD. He is an Osteoporosis Essentials Course instructor, serves on the OE Update Committee and CME Committee. He was awarded Clinical Densitometrist of the year in 2007 by the ISCD and was Co-Chair of the ISCD Annual Meeting in 2006. He is a reviewer for the Journal of Clinical Densitometry and is on the editorial board of Therapeutic Advances in Musculoskeletal disease. He has also participated in numerous advisory boards and has given a variety of CME presentations. His research has been presented in regional, national, and international academic meetings.

    Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen

    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD - Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD - No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD - Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD - No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT - No Financial Relationships to Disclose 
    Brian Englander, MD - No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD - No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT - No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, - CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD - No Financial Relationships to Disclose

    December 2023 Course Faculty

    Christopher R. Shuhart, MD, MHA - No Financial Relationships to Disclose
    Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
    S. Bobo Tanner, MD, CCD Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 12/03/2023 at 10:00 AM (EST)

    Course Date: December 3, 2023. This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures. Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting.

    Course Date

    December 3, 2023

    Course Description

    This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures.  Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting. It is recommended, but not required, that registrants attend the Osteoporosis Essentials/Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the VFR course


    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, nuclear medicine, physical and occupational therapy, and research. The course is also appropriate for technologists.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Summarize best-practice methods utilized to recognize vertebral fractures on lateral spine images. 2. Describe non-fracture abnormalities that may appear on a spine image. 3. Identify characteristics of high-quality densitometric lateral spine images. 4. Identify the appropriate complementary technologies to complete vertebral fracture assessment. 5. Cite indications for VFA as stated in the 2015 ISCD Official Positions.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 3, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 4.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - December 3, 2023 - All times eastern (NYC/USA)

    image


    John Schousboe, MD, PhD, CCD

    Director, Park Nicollet Bone Densitometry Center; Consultant Rheumatologist, Park Nicollet Clinic; Research Investigator, HealthPartners Institute

    Dr. Schousboe is a rheumatologist and health services researcher who directs the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system in Minneapolis, MN. He is an a Past President of the International Society for Clinical Densitometry (ISCD) and a Fellow of the American Society for Bone and Mineral Research (ASBMR). During a 16-year research career he has been an author on 200 peer-reviewed publications, the far majority of which have been in the field of diagnosis and management of osteoporosis. His contributions to science include development of a cost-effectiveness model that was used to conduct studies of the cost-effectiveness of bone densitometry in men and subgroups of older women and men defined by prevalent vertebral fracture, bone turnover marker levels, and bone density level; studies of the accuracy, prevalence, and clinical impact of vertebral fracture recognition on bone density lateral spine images; studies of medication adherence to osteoporosis therapies; studies of the identification and clinical significance of abdominal aortic calcification on lateral bone density spine images; and predictors of health care utilization and costs using Medicare Claims data.

    No Financial Relationships to Disclose 

    E. Michael Lewiecki, MD, FACP, FACE, CCD

    Director

    New Mexico Clinical Research & Osteoporosis Center, Inc.

    E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

    Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    Course Planning Committee

    Tamara Vokes, MD, CCD No Financial Relationships to Disclose
    Brad Richmond, MD, FACR,CCD No Financial Relationships to Disclose
    John Schouseboe, MD, PhD, CCD No Financial Relationships to Disclose
    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Edwin Oei, MD, PhD No Financial Relationships to Disclose

    Course Content Reviewers

    Campbell Macgregor, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M) CBDT No Financial Relationships to Disclose
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose
    Merle Wigeson, MD No Financial Relationships to Disclose

    December 2023 Course Faculty

    John Schousboe, MD, PhD, CCD No Financial Relationships to Disclose
    E. Michael Lewiecki, MD, FACP, FACE Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 11/04/2023 at 10:00 AM (EDT)

    Course Date: November 4, 2023. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Course Date

    November 4, 2023

    Course Description

    This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
    2. List other methods of body composition analysis used in the clinical setting.
    3. Differentiate reference values and indices.
    4. Identify limitations of reference values and indices.
    5. Summarize scan acquisition for adult and pediatric patients.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on November 4, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

    Rates

    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity is pending ASRT approval.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - November 4, 2023 - All times eastern (NYC/USA)
    image


    Adam Kuchnia

    Assistant Professor at the University of Wisconsin-Madison

    Adam Kuchnia is an Assistant Professor at the University of Wisconsin-Madison in the Department of Nutritional Sciences and holds a joint appointment within the Department of Surgery at the University of Wisconsin School of Medicine and Public health. The overall goal of his laboratory is to use a translational research approach to understand the mechanisms involved in the pathogenesis and the clinical implications of myosteatosis (i.e. muscle quality), or the infiltration of fat within muscle tissue, in aging and age-related disease. He has expertise in various imaging modalities for the assessment of muscle and in protein/muscle metabolism. Currently, his research focuses on human nutrition, in vivo lean tissue/muscle imaging and ex vivo measures to assess muscle and metabolic dysfunction. Adam is particularly interested in novel applications to refine protein recommendations with the goal of preserving muscle mass and muscle quality, while preventing consequential outcomes seen in aging and age-related disease. His research also aims to develop novel, noninvasive methods to accurately detect muscle wasting and myosteatosis and monitor changes in skeletal muscle while optimizing therapeutic intervention throughout medical treatment and surgery, including chemotherapy/immunotherapy and transplantation.

    No financial relationships to disclose

    John Shepherd PhD, CCD

    Researcher/Professor at the UH Cancer Center

    John Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar and an expert in mining biomarkers from medical imaging using advanced machine learning techniques; Co-I San Francisco Mammography Registry 1999-2018; PI of the NIH-funded 3-Component Breast Imaging Study; Director of the Artificial Intelligence Precision Health Institute, the Body Composition Exercise Physiology and Energy Metabolism CORE lab, and the Shepherd Research Lab; 2017 President of the International Society for Clinical Densitometry; ISCD’s John Bilezikian Global Leadership and Oscar Gluck Humanitarian Awards for his IAEA contributions. He has chaired 10 international workshops on quantitative imaging and has over 200 peer-reviewed publications that have been referenced over 10,000 times.

    Disclosure(s): GE Healthcare: Contracted Research (PI’s must provide disclosure in this category) (Ongoing); Hologic, Inc: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

    Course Planning Committee

    Ian Entwistle No Financial Relationships to Disclose
    Karen Hind, PhD, No Financial Relationships to Disclose
    Gary Slater No Financial Relationships to Disclose
    Michelle Swainson, BSc, MSc, PhD No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose

    Course Content Reviewers

    Suresh Kumar, MD, CCD No Financial Relationships to Disclose
    William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M), CBDT No Financial Relationships to Disclose
    Vani Selvan, MD, CCD No Financial Relationships to Disclose

    November 2023 Course Faculty

    Adam Kuchina No Financial Relationships to Disclose
    Dr. John A. Shepherd, PhD, CCD Contracted Research- Hologic, Inc-Investigator Initiated Study; GE Healthcare-Investigator Initated Study; Ownership Interest-BodySpec-Stock Options for Scientific Advisory Board

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 10/28/2023 at 10:00 AM (EDT)

    Course Date: October 28, 2023. The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.

    Course Date

    October 28, 2023

    Course Description

    The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.


    Target Audience

    The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify the most appropriate and reproducible sites for densitometry in children and adolescents.
    2. Outline the corrections in DXA measurements that should be made when acquiring assessments in children and adolescents.
    3. Describe the uses of measurement tools for acquiring bone densitometry assessments including DXA, as well as those other than DXA.
    4. Summarize the elements that should be included in a DXA report for a child or adolescent.
    5. Recognize issues that arise in children with chronic disease(s) that many times arise in the skeletal assessment.


    Method of Participation

    This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on October 28, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

     It is anticipated that this learning activity will be approved for a maximum 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    It is anticipated that this activity will be approved for 4.50 Category A continuing education credits.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Dr. Neil Jacob Paloian

    Assistant Professor (CHS), Department of Pediatrics, Division of Nephrology

    University of Wisconsin School of Medicine and Public Health

    Neil Paloian, MD is Associate Professor of Pediatrics at the University of Wisconsin School of Medicine and Public Health division of Nephrology. He is the director of the multi-disciplinary Pediatric Bone and Mineral Metabolism Clinic at the UW American Familiy Children’s Hospital. Dr Paloian specializes in the evaluation and treatment of children with acquired or inherited bone disorders such as pediatric osteoporosis, osteogenesis imperfecta, X-linked hypophosphatemic rickets, and hypophosphatasia. Dr Paloian also directs the Pediatric Kidney Stone clinic at UW. His research focuses on better understanding disorders of mineral disease in children, including both bone mineralization and renal calcifications. 

    Disclosures: Fees for Non-CME Services: Ultragenyx

    Dr. Nina Ma, MD, CCD

    Associate Professor of Pediatrics

    University of Colorado School of Medicine

    Nina Ma, MD CCD is Associate Professor of Pediatrics at the University of Colorado School of Medicine. She is the Director and Founder of the Bone and Mineral Metabolism Program and holds the Kerr Family Endowed Chair in Endocrinology at Children’s Hospital Colorado. Early-on in her career, Dr. Ma established an interest in pediatric disorders of bone and mineral metabolism. Her current areas of clinical focus and research are in rare disorders, such as multicentric carpotarsal osteolysis, autosomal dominant hypoparathyroidism and X-linked hypophosphatemic rickets.

    Disclosures: Contracted Research: Ascendis Pharma, Ultragenyx, Calcilytix Royalty: UpToDate, Current Osteoporosis Reports.

    Course Planning Committee

    Tamara Vokes, MD, CCD No Financial Relationships to Disclose
    Brad Richmond, MD, FACR,CCD No Financial Relationships to Disclose
    John Schouseboe, MD, PhD, CCD No Financial Relationships to Disclose
    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Edwin Oei, MD, PhD No Financial Relationships to Disclose

    Course Content Reviewers

    Campbell Macgregor, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M) CBDT No Financial Relationships to Disclose
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose
    Merle Wigeson, MD No Financial Relationships to Disclose

    October 2023 Course Faculty

    Neil Jacob Paloian, MD Disclosures: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus)
    Nina Ma, MD, CCD Disclosures: Contracted Research: Ascendis Pharma, Ultragenyx, Calcilytix Royalty: UpToDate, Current Osteoporosis Reports

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 09/09/2023 at 10:00 AM (EDT)

    Course Date: September 9 & 10, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    September 9 & 10, 2023.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices.
    2. Perform a precision assessment and appreciate the requirement for clinical care.  
    3. Identify the anatomy relevant to clinical DXA scanning. 
    4. Implement consistent and appropriate technical acquisition and analysis techniques.  
    5. Perform a fracture risk assessment using FRAX. 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
    7. Understand how specific medical conditions and medications affect bone density. 
    8. Demonstrate how to access features within the DXA software. 
    9. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
    10. Recognize how technical errors impact clinical interpretation and patient care.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on September 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Registration Fee

    image



    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 13.0 Category A continuing education credits.

    Date of most recent Review or Update: This activity was most recently reviewed and renewed March 24, 2023.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - Day 1 - All times Eastern (NYC/USA)

    image

    Schedule - Day 2 - All times Eastern (NYC/USA)

    image

    Maureen A. Costello, AAS, RT(R), CBDT

    Radiologic Technologist

    University of Chicago Hospitals

    Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.

    Disclosure: No Financial Relationships to Disclose

    Lawrence G. Jankowski, CBDT

    Chief DXA Technologist/Research Coordinator

    Illinois Bone and Joint Institute, LLC

    Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.

    In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.

    Disclosure: No Financial Relationships to Disclose

    Anita Colquhoun, RTNM, MRT(N), CDT

    Charge Technologist

    Women's College Hospital

    Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

    Disclosure: No Financial Relationships to Disclose.

    Course Planning Committee

    JoAnn Caudill, RT(R)(M)(BD), CBDT  No Financial Relationships to Disclose 
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose 
    Larry G. Jankowski, CBDT No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
    Michelle Kochanski ,BSIT, RT(R), CBDT No Financial Relationships to Disclose 
    Diane Krueger, BS, CBDT Consulting Fee: Amgen; Contracted Research: Radius

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    September 2023 Course Faculty

    Anita Colquhoun, RTNM, MRT(N), CDT; No Financial Relationships to Disclose
    Maureen Costello, AAS, RT(R), CBDT No Financial Relationships to Disclose
    Larry G. Jankowski, CBDT No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 09/09/2023 at 10:00 AM (EDT)

    Course Date: September 9 & 10, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    September 9 & 10, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Sarah L. Morgan, MD, RD, CCD

    Professor, Medical Director UAB Osteoporosis Clinic and DXA Facility

    University of Alabama at Birmingham

    Dr. Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham. She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is s past President of the International Society for Clinical Densitometry and a past chair of the ISCD Education Council.

    Disclosures: No Financial Relationships to Disclose

    Steven M. Petak, MD, JD, MACE, FACP

    Division Head and Clinical Service Chief Endocrinology

    Houston Methodist Hospital

    Dr. Steven Petak is a clinical and academic endocrinologist in Houston, Texas.

    He is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org). He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor.

    His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.

    He received his MD from the University of Illinois in Chicago and has his JD from the University of Houston (Magna cum Laude). He had his internship, residency, medical chief residency, and fellowship in endocrinology and metabolism at the University of Texas at Houston. He was at the Texas Institute for Reproductive Medicine and Endocrinology in Houston for about 26 years before joining the academic endocrine group at Methodist in May 2013. He is board certified in internal medicine as well as endocrinology and metabolism.

    Disclosures: Fees for Non-CME Services: Amgen, Alexion, Shire, Alexion 

    E. Michael Lewiecki, MD, FACP, FACE, CCD

    Director

    New Mexico Clinical Research & Osteoporosis Center, Inc.

    E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

    Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD - Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD - No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD - Consulting Fees: AMDA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD - No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT - No Financial Relationships to Disclose 
    Brian Englander, MD - No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD - No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT - No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, - CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD - No Financial Relationships to Disclose

    September 2023 Course Faculty

    Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose
    Steven M. Petak, MD, JD, MACE, FACP - Fees for Non-CME Services: Amgen, Alexion
    E. Michael Liewicki, Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 06/10/2023 at 10:00 AM (EDT)

    Course Date: June 10 & 11, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data, and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive, and informative. The course emphasizes technical excellence in the performance, analysis, and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    June 10 10:00 AM-5:30 PM ET

    June 11 9:30 AM-2:15 PM ET


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data, and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive, and informative. The course emphasizes technical excellence in the performance, analysis, and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices
    2. Perform a precision assessment and appreciate the requirement for clinical care  
    3. Identify the anatomy relevant to clinical DXA scanning 
    4. Implement consistent and appropriate technical acquisition and analysis techniques  
    5. Perform a fracture risk assessment using FRAX 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report 
    7. Understand how specific medical conditions and medications affect bone density 
    8. Demonstrate how to access features within the DXA software 
    9. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods 
    10. Recognize how technical errors impact clinical interpretation and patient care

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on June 10 & 11, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Registration Fee

    image



    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is cancelled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 13.0 Category A continuing education credits.

    Date of most recent Review or Update: This activity was most recently reviewed and renewed March 24, 2023.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - Day 1 - All times Eastern (NYC/USA)

    image

     Schedule - Day 2 - All times Eastern (NYC/USA)

    image

    Maureen A. Costello, AAS, RT(R), CBDT

    Radiologic Technologist

    University of Chicago Hospitals

    Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.

    Disclosure: No Financial Relationships to Disclose

    Lawrence G. Jankowski, CBDT

    Chief DXA Technologist/Research Coordinator

    Illinois Bone and Joint Institute, LLC

    Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.

    In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.

    Disclosure: No Financial Relationships to Disclose

    Anita Colquhoun, RTNM, MRT(N), CDT

    Charge Technologist

    Women's College Hospital

    Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

    Disclosure: No Financial Relationships to Disclose.

    Course Planning Committee

    JoAnn Caudill, RT(R)(M)(BD), CBDT  No Financial Relationships to Disclose 
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose 
    Larry G. Jankowski, CBDT No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
    Michelle Kochanski ,BSIT, RT(R), CBDT No Financial Relationships to Disclose 
    Maureen Costello, RT(R), AAS, CBDT No Financial Relationships to Disclose 
    Diane Krueger, BS, CBDT Consulting Fee: Amgen; Contracted Research: Radius

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    June 2023 Course Faculty

    Lawrence Jankowski, CBDT No Financial Relationships to Disclose
    Maureen Costello, RT(R), AAS, CBDT No Financial Relationships to Disclose
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity.

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is cancelled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

  • Includes Multiple Live Events. The next is on 06/10/2023 at 10:00 AM (EDT)

    Course Date: June 10 & 11, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    June 10 & 11, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on June 10 & 11, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Sarah L. Morgan, MD, RD, CCD

    Professor, Medical Director UAB Osteoporosis Clinic and DXA Facility

    University of Alabama at Birmingham

    Dr. Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham. She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is s past President of the International Society for Clinical Densitometry and a past chair of the ISCD Education Council.

    Disclosures: No Financial Relationships to Disclose

    Steven M. Petak, MD, JD, MACE, FACP

    Division Head and Clinical Service Chief Endocrinology

    Houston Methodist Hospital

    Dr. Steven Petak is a clinical and academic endocrinologist in Houston, Texas.

    He is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org). He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor.

    His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.

    He received his MD from the University of Illinois in Chicago and has his JD from the University of Houston (Magna cum Laude). He had his internship, residency, medical chief residency, and fellowship in endocrinology and metabolism at the University of Texas at Houston. He was at the Texas Institute for Reproductive Medicine and Endocrinology in Houston for about 26 years before joining the academic endocrine group at Methodist in May 2013. He is board certified in internal medicine as well as endocrinology and metabolism.

    Disclosures: Fees for Non-CME Services: Amgen, Alexion, Shire, Alexion 

    Gillian Wooldridge, DO, CCD

    Gillian Wooldridge is a primary care sports medicine physician in Houston, Texas. She completed her undergraduate studies in Kinesiology-Sports Medicine at Rice University in 2009. She received her medical degree from the Texas College of Osteopathic Medicine in 2014, where she was the inaugural recipient of the Sports Medicine Achievement Award. Dr Wooldridge completed her family medicine residency in 2017 and sports medicine fellowship in 2018, with Houston Methodist and Houston Methodist Willowbrook Hospitals respectively. 

    She currently works for Houston Methodist Orthopedics and Sports Medicine in the Texas Medical Center. She serves as a team physician for Rice University Athletics and volunteers with several organizations in the community including the Chevron Houston Marathon, IronMan Texas and the Houston Livestock Show and Rodeo. Dr Wooldridge is a member of the board of directors for the American Osteopathic Academy of Sports Medicine and is actively involved in the American Medical Society of Sports Medicine as an item writer for the sports medicine in-training exam. 

    She is a certified clinical densitometrist and works on the Osteoporosis Essentials Course Committee and serves as a co-director of the Bone Health Initiative in the Houston Methodist Orthopedics and Sports Medicine department. She holds a core clinical faculty position with the Texas A&M College of Medicine Engineering & Medicine program and a clinical faculty position the Tillman Fertitta Family College of Medicine. 

    Disclosures: No Financial Relationships to Disclose

    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT  Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD< CCD No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD Consulting Fees: AMDA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    June 2023 Course Faculty

    Sarah Morgan, MD, RD, CCD No Financial Relationships to Disclose
    Steven M. Petak, MD, JD, MACE, FACP Fees for Non-CME Services: Amgen, Alexion
    Gillian G. Woolridge, DO, CCD No Financial Relationships to Disclose

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • DXA is critical to the assessment and management of patients with osteoporosis. We will review the current evidence on the benefits and limitations of serial DXA assessment in clinical practice.

    Activity approved for 1.00 ASRT Category A Credits
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
    Activity Expires June 1, 2024

    Activity Description

    DXA is critical to the assessment and management of patients with osteoporosis. We will review the current evidence on the benefits and limitations of serial DXA assessment in clinical practice.

    Learning Objectives:

    1. List ISCD positions related to least significant change (LSC) for monitoring BMD change. 2. Explain the benefits and controversies in BMD monitoring of untreated patients. 3. Explain the benefits and controversies in BMD monitoring of patients receiving anti-osteoporosis therapy.

    Instructions:

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

    On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.00 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on April 18, 2023, and will expire on June 1, 2024.

    William Leslie, MD, MSc, CCD

    Professor of Medicine and Radiology

    University of Manitoba

    Dr. Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 450 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing and other nuclear diagnostic techniques. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, Director of the Manitoba Bone Density Program, and Co-Director of the Winnipeg PET Imaging Centre.

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Fiore Barbini - No Financial Relationships to Disclose

    Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose

    Harold Rosen, MD, CCD -  No Financial Relationships to Disclose

    Course Content Reviewers

    Wendy Tolman-Andrews -  No Financial Relationships to Disclose

    Content Authors

    Dr William Leslie, MD, FRCPC, MSc, CCD - No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.